Treatment of osteoarthritis of the knee: Evidence-based guideline, 2nd edition

Journal of the American Academy of Orthopaedic Surgeons

Volumn 21, Issue 9, 2013, Pages 571-576

  Jevsevar, David S ^a  

^a Zion Orthopaedics and Sports Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVIDENCE BASED MEDICINE; HUMAN; KNEE OSTEOARTHRITIS; METHODOLOGY; ORTHOPEDICS; PRACTICE GUIDELINE; REVIEW;

EVIDENCE-BASED MEDICINE; HUMANS; ORTHOPEDICS; OSTEOARTHRITIS, KNEE; PRACTICE GUIDELINES AS TOPIC;

EID: 84885445625     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/JAAOS-21-09-571     Document Type: Review

References (14)

1. American Academy of Orthopaedic Surgeons: Treatment of Osteoarthritis of the Knee: Evidence-Based Guideline, 2nd Edition. Available at: http://www.aaos.org/research/guidelines/Treatmentof OsteoarthritisoftheKneeGuideline.pdf. Accessed July 18, 2013.
2. US Department of Health & Human Services: Agency for Healthcare Research and Quality. National Guideline Clearinghouse: FAQ: NGC's Revised Inclusion Criteria. Available at: http://www.guideline.gov/faq.aspx. Accessed July 17, 2013.
3. Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N: Treatment of Primary and Secondary Osteoarthritis of the Knee. Rockville, MD, Agency for Healthcare Research and Quality. AHRQ publication no. 07-E012, September 2001. Report number157. Available at: http://archive.ahrq.gov/ downloads/pub/evidence/pdf/oaknee/oaknee.pdf. Accessed July 15, 2013.
4. Zhang W, Moskowitz RW, Nuki G, et al: OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidencebased, expert consensus guidelines. Osteoarthritis Cartilage 2008;16(2):137-162.
5. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;19(2):CD005321.
6. Sharma R, Vannabouathong C, Bains S, et al: Meta-analyses in joint arthroplasty: A review of quantity, quality, and impact. J Bone Joint Surg Am 2011;93(24):2304-2309.
7. Jevsevar DS: The importance of clinical significance in AAOS CPGs. AAOS Now May 2013. Available at: http://www.aaos.org/news/aaosnow/may13/research2. asp. Accessed May 9, 2013.
8. Rutjes AW, Jüni P, da Costa BR, Trelle S, Nüesch E, Reichenbach S: Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis. Ann Intern Med 2012;157(3):180-191.
9. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM: Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86(3):538-545.
10. Angst F, Aeschlimann A, Michel BA, Stucki G: Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. J Rheumatol 2002;29(1):131-138.
11. Angst F, Aeschlimann A, Stucki G: Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum 2001;45(4):384-391.
12. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS: Interpreting treatment effects in randomised trials. BMJ 1998;316(7132):690-693.
13. Tubach F, Wells GA, Ravaud P, Dougados M: Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: Methodological issues. J Rheumatol 2005;32(10):2025-2029.
14. Straus SE, Glasziou P, Richardson WS, Haynes RB: Evidence-Based Medicine: How to Practice and Teach It, ed 4. Edinburgh, UK, Churchill Livingstone Elsevier, 2011.